MARCEE STEGEMEIER: Open Payments
NPI 1639316946 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,844 in 152 payments from 18 companies in 2025. Trend: 2023 $2,766 · 2024 $3,120 · 2025 $2,844
Food & beverage: $2,824Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $549 |
| GlaxoSmithKline, LLC. | 38 | $456 |
| HARMONY BIOSCIENCES LLC | 11 | $335 |
| Insmed, Inc. | 14 | $219 |
| Merck Sharp & Dohme LLC | 8 | $208 |
| Regeneron Healthcare Solutions, Inc. | 9 | $186 |
| GENZYME CORPORATION | 7 | $156 |
| Grifols USA, LLC | 11 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $136 |
| Inspire Medical Systems, Inc. | 1 | $104 |
Products named: TRELEGY ELLIPTA, DUPIXENT, WAKIX, TEZSPIRE, Arikayce, ZERBAXA, FASENRA, Prolastin-C Liquid.
Industry payments across MO — which companies pay providers there.
